Physician profile
Alexander Reznikov
NPI 1063851301
$1,685.42
in general payments reported to CMS, 2019-2025
9 companies · $216 in 2025
The $216 reported for 2025 was more than what 77% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $210 · 2021: $281 · 2022: $189 · 2023: $416 · 2024: $42.21 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444 · Gift: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.81 |
| Gift | $230.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $727.28 | 2019-2025 | Invisalign, Itero Element 5d Plus, Itero Element 2 Plus Mobile |
| Implant Direct Sybron International LLC | $395.92 | 2019-2022 | |
| Ultradent Products INC | $235.07 | 2023-2024 | Opalescence |
| Biohorizons Implant Systems INC. | $98.81 | 2022 | |
| Tulsa Dental Products LLC | $84.87 | 2020 | |
| Straumann USA LLC | $64.00 | 2021-2022 | |
| Nobel Biocare USA | $46.34 | 2023 | Nobelactive |
| Sonendo INC | $18.75 | 2024 | Gentlewave G4 Console |
| Geistlich Pharma, North America, INC. | $14.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Reznikov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.